Narayanan S
Department of Pathology, New York Medical College/Metropolitan Hospital Center NY 10029.
Ann Clin Lab Sci. 1991 Jul-Aug;21(4):291-6.
The availability of a variety of restriction endonuclease enzymes that cleave deoxyribonucleic acid (DNA) at specific sites has made it possible to identify the presence of polymorphic regions in the isolated fragments. Such restriction fragment length polymorphism (RFLP) results owing to a variation in the number of tandem repeats (VNTR) of a short DNA segment. These VNTR sequences can uniquely specify an individual and, as such, are used in DNA fingerprinting and in paternity testing. Restriction fragment length polymorphism may be found close to a disease gene, and, as such, can be used as a genetic disease marker. Certain criteria need to be fulfilled, however, for RFLP to be useful as a genetic disease marker, such as its closeness to the disease gene. Materials and methodology for detecting RFLP are reviewed with the current emphasis on amplification procedures utilizing the polymerase chain reaction (PCR).
多种能在特定位点切割脱氧核糖核酸(DNA)的限制性内切酶的出现,使得鉴定分离片段中多态性区域的存在成为可能。这种限制性片段长度多态性(RFLP)是由于短DNA片段串联重复序列(VNTR)数量的变化所致。这些VNTR序列可以唯一地确定一个个体,因此被用于DNA指纹识别和亲子鉴定。限制性片段长度多态性可能在疾病基因附近被发现,因此可用作遗传疾病标记。然而,RFLP要用作遗传疾病标记需要满足某些标准,比如它与疾病基因的接近程度。本文综述了检测RFLP的材料和方法,目前重点是利用聚合酶链反应(PCR)的扩增程序。